{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:57:34Z","timestamp":1788577054481,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY030838-01"],"award-info":[{"award-number":["1R01EY030838-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The maintenance of complex dendritic arbors and synaptic transmission are processes that require a substantial amount of energy. Bioenergetic decline is a prominent feature of chronic neurodegenerative diseases, yet the signaling mechanisms that link energy stress with neuronal dysfunction are poorly understood. Recent work has implicated energy deficits in glaucoma, and retinal ganglion cell (RGC) dendritic pathology and synapse disassembly are key features of ocular hypertension damage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We show that adenosine monophosphate-activated protein kinase (AMPK), a conserved energy biosensor, is strongly activated in RGC from mice with ocular hypertension and patients with primary open angle glaucoma. Our data demonstrate that AMPK triggers RGC dendrite retraction and synapse elimination. We show that the harmful effect of AMPK is exerted through inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Attenuation of AMPK activity restores mTORC1 function and rescues dendrites and synaptic contacts. Strikingly, AMPK depletion promotes recovery of light-evoked retinal responses, improves axonal transport, and extends RGC survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study identifies AMPK as a critical nexus between bioenergetic decline and RGC dysfunction during pressure-induced stress, and highlights the importance of targeting energy homeostasis in glaucoma and other neurodegenerative diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13024-021-00466-z","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:02:46Z","timestamp":1624971766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Nicolas","family":"Belforte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Agostinone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alarcon-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Villafranca-Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dotigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Cueva Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-0760","authenticated-orcid":false,"given":"Adriana","family":"Di Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","unstructured":"Harris JJ, Jolivet R, Attwell D. Synaptic energy use and supply. Neuron. 2012;75(5):762-77. https:\/\/doi.org\/10.1016\/j.neuron.2012.08.019.","DOI":"10.1016\/j.neuron.2012.08.019"},{"issue":"3","key":"466_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","volume":"12","author":"MTT Wong-Riley","year":"1989","unstructured":"Wong-Riley MTT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989;12(3):94\u2013101. https:\/\/doi.org\/10.1016\/0166-2236(89)90165-3.","journal-title":"Trends Neurosci"},{"issue":"15","key":"466_CR3","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/1873-3468.13802","volume":"594","author":"M Markaki","year":"2020","unstructured":"Markaki M, Tavernarakis N. Mitochondrial turnover and homeostasis in ageing and neurodegeneration. FEBS Lett. 2020;594(15):2370\u20139.","journal-title":"FEBS Lett"},{"issue":"7","key":"466_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio Compagnoni","year":"2020","unstructured":"Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E. The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Mol Neurobiol. 2020;57(7):2959\u201380. https:\/\/doi.org\/10.1007\/s12035-020-01926-1.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"466_CR5","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/ijms21103719","volume":"21","author":"S Stanga","year":"2020","unstructured":"Stanga S, Caretto A, Boido M, Vercelli A. Mitochondrial dysfunctions: a red thread across neurodegenerative diseases. Int J Mol Sci. 2020;21(10):3719.","journal-title":"Int J Mol Sci"},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mito.2017.08.014","volume":"36","author":"YA Ito","year":"2017","unstructured":"Ito YA, Di Polo A. Mitochondrial dynamics, transport, and quality control: a bottleneck for retinal ganglion cell viability in optic neuropathies. Mitochondrion. 2017;36:186\u201392. https:\/\/doi.org\/10.1016\/j.mito.2017.08.014.","journal-title":"Mitochondrion."},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/bs.pbr.2015.04.012","volume":"220","author":"J Agostinone","year":"2015","unstructured":"Agostinone J, Di Polo A. Retinal ganglion cell dendrite pathology and synapse loss: implications for glaucoma. Prog Brain Res. 2015;220:199\u2013216. https:\/\/doi.org\/10.1016\/bs.pbr.2015.04.012.","journal-title":"Prog Brain Res"},{"issue":"1","key":"466_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5483\/BMBRep.2017.50.1.131","volume":"50","author":"JH Kweon","year":"2017","unstructured":"Kweon JH, Kim S, Lee SB. The cellular basis of dendrite pathology in neurodegenerative diseases. BMB Rep. 2017;50(1):5\u201311. https:\/\/doi.org\/10.5483\/BMBRep.2017.50.1.131.","journal-title":"BMB Rep"},{"issue":"45","key":"466_CR9","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.1523\/JNEUROSCI.2360-16.2016","volume":"36","author":"Z Yan","year":"2016","unstructured":"Yan Z, Kim E, Datta D, Lewis DA, Soderling SH. Synaptic actin dysregulation, a convergent mechanism of mental disorders? J Neurosci. 2016;36(45):11411\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.2360-16.2016.","journal-title":"J Neurosci"},{"issue":"2","key":"466_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WNO.0b013e318177edf0","volume":"28","author":"JB Morquette","year":"2008","unstructured":"Morquette JB, Di Polo A. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon? J Neuroophthalmol. 2008;28(2):144\u201354. https:\/\/doi.org\/10.1097\/WNO.0b013e318177edf0.","journal-title":"J Neuroophthalmol"},{"key":"466_CR11","doi-asserted-by":"publisher","unstructured":"Burkewitz K , Zhang Y , Mair WB. AMPK at the nexus of energetics and aging. Cell Metab. 2014;20(1):10-25. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.002.","DOI":"10.1016\/j.cmet.2014.03.002"},{"issue":"3","key":"466_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie DG, Schaffer B, Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 2016;26(3):190\u2013201. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.013.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"466_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1432-1033.1991.tb16172.x","volume":"199","author":"F Moore","year":"1991","unstructured":"Moore F, Weekes J, Hardie DG. Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur J Biochem. 1991;199(3):691\u20137. https:\/\/doi.org\/10.1111\/j.1432-1033.1991.tb16172.x.","journal-title":"Eur J Biochem"},{"issue":"14","key":"466_CR14","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1073\/pnas.1013660108","volume":"108","author":"T Williams","year":"2011","unstructured":"Williams T, Courchet J, Viollet B, Brenman JE, Polleux F. AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress. Proc Natl Acad Sci U S A. 2011;108(14):5849\u201354. https:\/\/doi.org\/10.1073\/pnas.1013660108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2013.11.048","volume":"259","author":"S Ramamurthy","year":"2014","unstructured":"Ramamurthy S, Chang E, Cao Y, Zhu J, Ronnett GV. AMPK activation regulates neuronal structure in developing hippocampal neurons. Neuroscience. 2014;259:13\u201324. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.11.048.","journal-title":"Neuroscience."},{"issue":"9","key":"466_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nn.3772","volume":"17","author":"MA Samuel","year":"2014","unstructured":"Samuel MA, Voinescu PE, Lilley BN, de Cabo R, Foretz M, Viollet B, et al. LKB1 and AMPK regulate synaptic remodeling in old age. Nat Neurosci. 2014;17(9):1190\u20137. https:\/\/doi.org\/10.1038\/nn.3772.","journal-title":"Nat Neurosci"},{"issue":"11","key":"466_CR17","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology."},{"issue":"1","key":"466_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","volume":"13","author":"V Chrysostomou","year":"2013","unstructured":"Chrysostomou V, Rezania F, Trounce IA, Crowston JG. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol. 2013;13(1):12\u20135. https:\/\/doi.org\/10.1016\/j.coph.2012.09.008.","journal-title":"Curr Opin Pharmacol"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fnins.2017.00146","volume":"11","author":"DM Inman","year":"2017","unstructured":"Inman DM, Harun-Or-Rashid M. Metabolic vulnerability in the neurodegenerative disease glaucoma. Front Neurosci. 2017;11:146.","journal-title":"Front Neurosci"},{"issue":"1","key":"466_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/APO.0000000000000183","volume":"5","author":"T Nakazawa","year":"2016","unstructured":"Nakazawa T. Ocular blood flow and influencing factors for glaucoma. Asia Pac J Ophthalmol. 2016;5(1):38\u201344. https:\/\/doi.org\/10.1097\/APO.0000000000000183.","journal-title":"Asia Pac J Ophthalmol"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2016.04.032","volume":"787","author":"NN Osborne","year":"2016","unstructured":"Osborne NN, N\u00fa\u00f1ez-\u00c1lvarez C, Joglar B, del Olmo-Aguado S. Glaucoma: focus on mitochondria in relation to pathogenesis and neuroprotection. Eur J Pharmacol. 2016;787:127\u201333. https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.032.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"466_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/IJG.0000000000000767","volume":"26","author":"P Williams","year":"2017","unstructured":"Williams P, Harder J, John SWM. Glaucoma as a metabolic optic neuropathy: making the case for nicotinamide treatment in glaucoma. J Glaucoma. 2017;26(12):1161\u20138. https:\/\/doi.org\/10.1097\/IJG.0000000000000767.","journal-title":"J Glaucoma"},{"issue":"6326","key":"466_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, et al. Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science (New York, NY). 2017;355(6326):756\u201360.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"466_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12974-018-1346-7","volume":"15","author":"M Harun-Or-Rashid","year":"2018","unstructured":"Harun-Or-Rashid M, Inman DM. Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma. J Neuroinflamm. 2018;15(1):313.","journal-title":"J Neuroinflamm"},{"key":"466_CR25","first-page":"53731","volume":"109","author":"YA Ito","year":"2016","unstructured":"Ito YA, Belforte N, Cueva Vargas JL, Di Polo A. A magnetic microbead occlusion model to induce ocular hypertension-dependent glaucoma in mice. JoVE. 2016;109:53731.","journal-title":"JoVE."},{"issue":"4","key":"466_CR26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/j.1471-4159.2007.04843.x","volume":"103","author":"V Pernet","year":"2007","unstructured":"Pernet V, Bourgeois P, Di Polo A. A role for polyamines in retinal ganglion cell excitotoxic death. J Neurochem. 2007;103(4):1481\u201390. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04843.x.","journal-title":"J Neurochem"},{"key":"466_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nbd.2016.05.002","volume":"93","author":"J Cueva Vargas","year":"2016","unstructured":"Cueva Vargas J, Belforte N, Di Polo A. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase a signaling. Neurobiol Dis. 2016;93:156\u201371. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.002.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"466_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-5793(03)00560-X","volume":"546","author":"DG Hardie","year":"2003","unstructured":"Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546(1):113\u201320. https:\/\/doi.org\/10.1016\/S0014-5793(03)00560-X.","journal-title":"FEBS Lett"},{"issue":"12","key":"466_CR29","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1523\/JNEUROSCI.20-12-04615.2000","volume":"20","author":"S Leon","year":"2000","unstructured":"Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci. 2000;20(12):4615\u201326. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-12-04615.2000.","journal-title":"J Neurosci"},{"issue":"5","key":"466_CR30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1073\/pnas.91.5.1632","volume":"91","author":"S Mansour-Robaey","year":"1994","unstructured":"Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A. 1994;91(5):1632\u20136. https:\/\/doi.org\/10.1073\/pnas.91.5.1632.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"466_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/brain\/awr338","volume":"135","author":"HV Danesh-Meyer","year":"2012","unstructured":"Danesh-Meyer HV, Kerr NM, Zhang J, Eady EK, O'Carroll SJ, Nicholson LF, et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain. 2012;135(Pt 2):506\u201320. https:\/\/doi.org\/10.1093\/brain\/awr338.","journal-title":"Brain."},{"issue":"7823","key":"466_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-020-2589-x","volume":"585","author":"L Alarcon-Martinez","year":"2020","unstructured":"Alarcon-Martinez L, Villafranca-Baughman D, Quintero H, Kacerovsky JB, Dotigny F, Murai KK, et al. Interpericyte tunnelling nanotubes regulate neurovascular coupling. Nature. 2020;585(7823):91\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2589-x.","journal-title":"Nature."},{"issue":"1","key":"466_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","volume":"28","author":"G Feng","year":"2000","unstructured":"Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28(1):41\u201351. https:\/\/doi.org\/10.1016\/S0896-6273(00)00084-2.","journal-title":"Neuron."},{"issue":"4","key":"466_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/cdd.2014.149","volume":"22","author":"B Morquette","year":"2015","unstructured":"Morquette B, Morquette P, Agostinone J, Feinstein E, McKinney RA, Kolta A, et al. REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury. Cell Death Differ. 2015;22(4):612\u201325. https:\/\/doi.org\/10.1038\/cdd.2014.149.","journal-title":"Cell Death Differ"},{"key":"466_CR35","first-page":"192","volume":"7","author":"CL Schlamp","year":"2001","unstructured":"Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis. 2001;7:192\u2013201.","journal-title":"Mol Vis"},{"issue":"3","key":"466_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cub.2013.12.020","volume":"24","author":"A Bleckert","year":"2014","unstructured":"Bleckert A, Schwartz GW, Turner MH, Rieke F, Wong RO. Visual space is represented by nonmatching topographies of distinct mouse retinal ganglion cell types. Curr Biol. 2014;24(3):310\u20135. https:\/\/doi.org\/10.1016\/j.cub.2013.12.020.","journal-title":"Curr Biol"},{"issue":"2","key":"466_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1523\/JNEUROSCI.23-02-00518.2003","volume":"23","author":"J Johnson","year":"2003","unstructured":"Johnson J, Tian N, Caywood MS, Reimer RJ, Edwards RH, Copenhagen DR. Vesicular neurotransmitter transporter expression in developing postnatal rodent retina: GABA and glycine precede glutamate. J Neurosci. 2003;23(2):518\u201329. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-02-00518.2003.","journal-title":"J Neurosci"},{"issue":"4","key":"466_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","volume":"18","author":"GJ Gowans","year":"2013","unstructured":"Gowans GJ, Hawley SA, Ross FA, Hardie DG. AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 2013;18(4):556\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2013.08.019.","journal-title":"Cell Metab"},{"issue":"44","key":"466_CR39","doi-asserted-by":"publisher","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","volume":"271","author":"SA Hawley","year":"1996","unstructured":"Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem. 1996;271(44):27879\u201387. https:\/\/doi.org\/10.1074\/jbc.271.44.27879.","journal-title":"J Biol Chem"},{"key":"466_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cbpb.2017.11.001","volume":"224","author":"PM Craig","year":"2018","unstructured":"Craig PM, Moyes CD, LeMoine CMR. Sensing and responding to energetic stress: evolution of the AMPK network. Comp Biochem Physiol B Biochem Mol Biol. 2018;224:156\u201369. https:\/\/doi.org\/10.1016\/j.cbpb.2017.11.001.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"8","key":"466_CR41","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicol\u00e1s","year":"2009","unstructured":"Nadal-Nicol\u00e1s FM, Jim\u00e9nez-L\u00f3pez M, Sobrado-Calvo P, Nieto-L\u00f3pez L, C\u00e1novas-Mart\u00ednez I, Salinas-Navarro M, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve injured retinas. Invest Ophthalmol Vis Sci. 2009;50(8):3860\u20138. https:\/\/doi.org\/10.1167\/iovs.08-3267.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"466_CR42","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez AR, de Sevilla Muller LP, Brecha NC. The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol. 2014;522(6):1411\u201343. https:\/\/doi.org\/10.1002\/cne.23521.","journal-title":"J Comp Neurol"},{"issue":"8","key":"466_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167\u201374. https:\/\/doi.org\/10.1172\/JCI13505.","journal-title":"J Clin Invest"},{"issue":"3","key":"466_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1158\/1535-7163.MCT-13-0579","volume":"13","author":"X Liu","year":"2014","unstructured":"Liu X, Chhipa RR, Nakano I, Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther. 2014;13(3):596\u2013605. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0579.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"466_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214\u201326. https:\/\/doi.org\/10.1016\/j.molcel.2008.03.003.","journal-title":"Mol Cell"},{"issue":"7","key":"466_CR46","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/brain\/awy142","volume":"141","author":"J Agostinone","year":"2018","unstructured":"Agostinone J, Alarcon-Martinez L, Gamlin C, Yu W-Q, Wong ROL, Di Polo A. Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury. Brain. 2018;141(7):1963\u201380. https:\/\/doi.org\/10.1093\/brain\/awy142.","journal-title":"Brain."},{"issue":"12","key":"466_CR47","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1093\/emboj\/16.12.3693","volume":"16","author":"HBJ Jefferies","year":"1997","unstructured":"Jefferies HBJ, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamycin suppresses 5[prime] TOP mRNA translation through inhibition of p70s6k. EMBO J. 1997;16(12):3693\u2013704. https:\/\/doi.org\/10.1093\/emboj\/16.12.3693.","journal-title":"EMBO J"},{"issue":"21","key":"466_CR48","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.visres.2010.08.014","volume":"50","author":"L Alarc\u00f3n-Mart\u00ednez","year":"2010","unstructured":"Alarc\u00f3n-Mart\u00ednez L, Avil\u00e9s-Trigueros M, Galindo-Romero C, Valiente-Soriano J, Agudo-Barriuso M, Pdl V, et al. ERG changes in albino and pigmented mice after optic nerve transection. Vis Res. 2010;50(21):2176\u201387. https:\/\/doi.org\/10.1016\/j.visres.2010.08.014.","journal-title":"Vis Res"},{"issue":"2","key":"466_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/ICU.0000000000000241","volume":"27","author":"LJ Wilsey","year":"2016","unstructured":"Wilsey LJ, Fortune B. Electroretinography in glaucoma diagnosis. Curr Opin Ophthalmol. 2016;27(2):118\u201324. https:\/\/doi.org\/10.1097\/ICU.0000000000000241.","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"466_CR50","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1073\/pnas.0913141107","volume":"107","author":"SD Crish","year":"2010","unstructured":"Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107(11):5196\u2013201. https:\/\/doi.org\/10.1073\/pnas.0913141107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"466_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","volume":"157","author":"PA Williams","year":"2017","unstructured":"Williams PA, Marsh-Armstrong N, Howell GR, IIoA L. Glaucomatous neurodegeneration P. Neuroinflammation in glaucoma: a new opportunity. Exp Eye Res. 2017;157:20\u20137. https:\/\/doi.org\/10.1016\/j.exer.2017.02.014.","journal-title":"Exp Eye Res"},{"key":"466_CR52","doi-asserted-by":"publisher","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol. 2020. https:\/\/doi.org\/10.1111\/ceo.13818 Advance online publication.","DOI":"10.1111\/ceo.13818"},{"issue":"8","key":"466_CR53","doi-asserted-by":"publisher","first-page":"e70760","DOI":"10.1371\/journal.pone.0070760","volume":"8","author":"D Banerjee","year":"2013","unstructured":"Banerjee D, Banerjee A, Mookherjee S, Vishal M, Mukhopadhyay A, Sen A, et al. Mitochondrial genome analysis of primary open angle glaucoma patients. PLoS One. 2013;8(8):e70760. https:\/\/doi.org\/10.1371\/journal.pone.0070760.","journal-title":"PLoS One"},{"issue":"10","key":"466_CR54","doi-asserted-by":"publisher","first-page":"e76627","DOI":"10.1371\/journal.pone.0076627","volume":"8","author":"DW Collins","year":"2013","unstructured":"Collins DW, Gudiseva HV, Trachtman BT, Jerrehian M, Gorry T, Merritt Iii WT, et al. Mitochondrial sequence variation in African-American primary open-angle glaucoma patients. PLoS One. 2013;8(10):e76627. https:\/\/doi.org\/10.1371\/journal.pone.0076627.","journal-title":"PLoS One"},{"issue":"2","key":"466_CR55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1167\/iovs.13-12968","volume":"55","author":"JW Jeoung","year":"2014","unstructured":"Jeoung JW, Seong M-W, Park SS, Kim DM, Kim SH, Park KH. Mitochondrial DNA variant discovery in normal-tension glaucoma patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55(2):986\u201392. https:\/\/doi.org\/10.1167\/iovs.13-12968.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"466_CR56","first-page":"220","volume":"19","author":"M Kumar","year":"2013","unstructured":"Kumar M, Tanwar M, Faiq MA, Pani J, Shamsi MB, Dada T, et al. Mitochondrial DNA nucleotide changes in primary congenital glaucoma patients. Mol Vis. 2013;19:220\u201330.","journal-title":"Mol Vis"},{"issue":"6","key":"466_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s004170100309","volume":"239","author":"D Opial","year":"2001","unstructured":"Opial D, Boehnke M, Tadesse S, Lietz Partzsch A, Flammer J, Munier F, et al. Leber\u2019s hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2001;239(6):437\u201340. https:\/\/doi.org\/10.1007\/s004170100309.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"466_CR58","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","volume":"104","author":"NM Tran","year":"2019","unstructured":"Tran NM, Shekhar K, Whitney IE, Jacobi A, Benhar I, Hong G, et al. Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes. Neuron. 2019;104(6):1039\u201355.e12.","journal-title":"Neuron"},{"issue":"7","key":"466_CR59","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1021\/acs.jmedchem.5b01201","volume":"59","author":"M Miglianico","year":"2016","unstructured":"Miglianico M, Nicolaes GAF, Neumann D. Pharmacological targeting of AMP-activated protein kinase and opportunities for computer-aided drug design. J Med Chem. 2016;59(7):2879\u201393. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01201.","journal-title":"J Med Chem"},{"issue":"3","key":"466_CR60","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ymthe.2017.01.018","volume":"25","author":"D Liu","year":"2017","unstructured":"Liu D, Tang H, Li X-Y, Deng M-F, Wei N, Wang X, et al. Targeting the HDAC2\/HNF-4A\/miR-101b\/AMPK pathway rescues tauopathy and dendritic abnormalities in Alzheimer\u2019s disease. Mol Ther. 2017;25(3):752\u201364. https:\/\/doi.org\/10.1016\/j.ymthe.2017.01.018.","journal-title":"Mol Ther"},{"issue":"7","key":"466_CR61","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1172\/JCI133982","volume":"130","author":"HR Zimmermann","year":"2020","unstructured":"Zimmermann HR, Yang W, Kasica NP, Zhou X, Wang X, Beckelman BC, et al. Brain-specific repression of AMPK\u03b11 alleviates pathophysiology in Alzheimer's model mice. J Clin Invest. 2020;130(7):3511\u201327. https:\/\/doi.org\/10.1172\/JCI133982.","journal-title":"J Clin Invest"},{"issue":"A","key":"466_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","volume":"298","author":"C Peixoto","year":"2017","unstructured":"Peixoto C, de Oliveira W, SMdR A, AKS N. AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol. 2017;298(A):31\u201341. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.013.","journal-title":"Exp Neurol"},{"issue":"52","key":"466_CR63","doi-asserted-by":"publisher","first-page":"33619","DOI":"10.1073\/pnas.2014213117","volume":"117","author":"JM Harder","year":"2020","unstructured":"Harder JM, Guymer C, Wood JPM, Daskalaki E, Chidlow G, Zhang C, et al. Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. Proc Natl Acad Sci U S A. 2020;117(52):33619\u201327. https:\/\/doi.org\/10.1073\/pnas.2014213117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"466_CR64","doi-asserted-by":"publisher","first-page":"14959","DOI":"10.1038\/srep14959","volume":"5","author":"P Yang","year":"2015","unstructured":"Yang P, Zhao Y, Zhao L, Yuan J, Chen Y, Varghese Z, et al. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo. Sci Rep. 2015;5(1):14959. https:\/\/doi.org\/10.1038\/srep14959.","journal-title":"Sci Rep"},{"issue":"3","key":"466_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014;19(3):373\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001.","journal-title":"Cell Metab"},{"issue":"3","key":"466_CR66","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang Y, Westbrook R, Hill C, Boparai RK, Arum O, Spong A, et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. 2013;17(3):456\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2013.02.008.","journal-title":"Cell Metab"},{"issue":"6","key":"466_CR67","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/db09-1324","volume":"59","author":"VP Houde","year":"2010","unstructured":"Houde VP, Br\u00fbl\u00e9 S, Festuccia WT, Blanchard P-G, Bellmann K, Deshaies Y, et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes. 2010;59(6):1338\u201348. https:\/\/doi.org\/10.2337\/db09-1324.","journal-title":"Diabetes."},{"issue":"6076","key":"466_CR68","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","volume":"335","author":"DW Lamming","year":"2012","unstructured":"Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science (New York, NY). 2012;335(6076):1638\u201343.","journal-title":"Science (New York, NY)"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-021-00466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-021-00466-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-021-00466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:12:34Z","timestamp":1624972354000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-021-00466-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1186\/s13024-021-00466-z","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were approved by the Centre de recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CRCHUM) ethics committee and adhered to the Canadian Council on Animal Care guidelines. Human retinal tissue was obtained from the Human Eye Biobank for Research (HEBR, St. Michael\u2019s Hospital, Toronto, ON) and used in accordance with the Declaration of Helsinki after approval by the CRCHUM ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}